Cargando…

T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy

Allergen-specific immunotherapy (AIT) is the only treatment for type I allergy, which achieves long-lasting effects. Repeated subcutaneous applications of allergen extracts cause a protective antibody response and an immune deviation of T cells. In AIT with allergoids, chemically modified allergen e...

Descripción completa

Detalles Bibliográficos
Autores principales: Reithofer, Manuel, Boell, Simone Lisa, Kitzmueller, Claudia, Horak, Fritz, Bohle, Barbara, Jahn-Schmid, Beatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685201/
https://www.ncbi.nlm.nih.gov/pubmed/38034768
http://dx.doi.org/10.1016/j.heliyon.2023.e21878
_version_ 1785151577355452416
author Reithofer, Manuel
Boell, Simone Lisa
Kitzmueller, Claudia
Horak, Fritz
Bohle, Barbara
Jahn-Schmid, Beatrice
author_facet Reithofer, Manuel
Boell, Simone Lisa
Kitzmueller, Claudia
Horak, Fritz
Bohle, Barbara
Jahn-Schmid, Beatrice
author_sort Reithofer, Manuel
collection PubMed
description Allergen-specific immunotherapy (AIT) is the only treatment for type I allergy, which achieves long-lasting effects. Repeated subcutaneous applications of allergen extracts cause a protective antibody response and an immune deviation of T cells. In AIT with allergoids, chemically modified allergen extracts are injected. During a so-called special pre-seasonal application scheme, after the initial phase of applying increased doses of allergoids is followed by natural allergen exposure as a maintenance phase. The effectiveness of allergoid vaccines has been described regarding the improvement of clinical symptoms and the development of protective humoral responses. In this longitudinal observational study, we sought to investigate changes at the T cell level in pre-seasonal AIT with allergoid. Different subsets within CD4(+) and CD8(+) T cells were monitored by flow cytometry in PBMC of patients known to possess protective antibody responses. Compared to before treatment, a small early boost among allergenic Th cells was observed after 4 months of AIT. In line, a slight Th2 bias was observed after 4 months within circulating T follicular T cells, Tfh and Tfc, representing pre-existing memory Th2 cells. Furthermore, it was demonstrated that responsiveness of CD8(+) T cells to allergen stimulation decreased during the course of treatment. Apart from that, we found an influence of the meteorological season on the activation profile of Tfh and Tfc over the course of the treatment. Together, this is the first study investigating changes of different T cell subsets over the course of an allergoid AIT against airborne allergens. Our findings match previous reports on conventional AIT, especially the initial increase of Th2 responses. However, the observed changes were less pronounced which may be either due to the modification of allergens or to the reduced maintenance dose provided by natural allergen exposure compared to a perennial protocol.
format Online
Article
Text
id pubmed-10685201
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106852012023-11-30 T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy Reithofer, Manuel Boell, Simone Lisa Kitzmueller, Claudia Horak, Fritz Bohle, Barbara Jahn-Schmid, Beatrice Heliyon Research Article Allergen-specific immunotherapy (AIT) is the only treatment for type I allergy, which achieves long-lasting effects. Repeated subcutaneous applications of allergen extracts cause a protective antibody response and an immune deviation of T cells. In AIT with allergoids, chemically modified allergen extracts are injected. During a so-called special pre-seasonal application scheme, after the initial phase of applying increased doses of allergoids is followed by natural allergen exposure as a maintenance phase. The effectiveness of allergoid vaccines has been described regarding the improvement of clinical symptoms and the development of protective humoral responses. In this longitudinal observational study, we sought to investigate changes at the T cell level in pre-seasonal AIT with allergoid. Different subsets within CD4(+) and CD8(+) T cells were monitored by flow cytometry in PBMC of patients known to possess protective antibody responses. Compared to before treatment, a small early boost among allergenic Th cells was observed after 4 months of AIT. In line, a slight Th2 bias was observed after 4 months within circulating T follicular T cells, Tfh and Tfc, representing pre-existing memory Th2 cells. Furthermore, it was demonstrated that responsiveness of CD8(+) T cells to allergen stimulation decreased during the course of treatment. Apart from that, we found an influence of the meteorological season on the activation profile of Tfh and Tfc over the course of the treatment. Together, this is the first study investigating changes of different T cell subsets over the course of an allergoid AIT against airborne allergens. Our findings match previous reports on conventional AIT, especially the initial increase of Th2 responses. However, the observed changes were less pronounced which may be either due to the modification of allergens or to the reduced maintenance dose provided by natural allergen exposure compared to a perennial protocol. Elsevier 2023-11-10 /pmc/articles/PMC10685201/ /pubmed/38034768 http://dx.doi.org/10.1016/j.heliyon.2023.e21878 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Reithofer, Manuel
Boell, Simone Lisa
Kitzmueller, Claudia
Horak, Fritz
Bohle, Barbara
Jahn-Schmid, Beatrice
T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
title T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
title_full T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
title_fullStr T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
title_full_unstemmed T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
title_short T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
title_sort t-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685201/
https://www.ncbi.nlm.nih.gov/pubmed/38034768
http://dx.doi.org/10.1016/j.heliyon.2023.e21878
work_keys_str_mv AT reithofermanuel tcellsubsetchangesduringthefirstyearofpreseasonalallergoidallergenspecificimmunotherapy
AT boellsimonelisa tcellsubsetchangesduringthefirstyearofpreseasonalallergoidallergenspecificimmunotherapy
AT kitzmuellerclaudia tcellsubsetchangesduringthefirstyearofpreseasonalallergoidallergenspecificimmunotherapy
AT horakfritz tcellsubsetchangesduringthefirstyearofpreseasonalallergoidallergenspecificimmunotherapy
AT bohlebarbara tcellsubsetchangesduringthefirstyearofpreseasonalallergoidallergenspecificimmunotherapy
AT jahnschmidbeatrice tcellsubsetchangesduringthefirstyearofpreseasonalallergoidallergenspecificimmunotherapy